Search results
Results from the WOW.Com Content Network
Eli Lilly (July 8, 1838 – June 6, 1898) was a Union Army officer, pharmacist, chemist, and businessman who founded Eli Lilly and Company. Lilly enlisted in the Union Army during the American Civil War and recruited a company of men to serve with him in the 18th Independent Battery Indiana Light Artillery .
Eli Lilly pleaded guilty to a US federal criminal misdemeanor charge of illegally marketing Zyprexa, actively promoting the drug for off-label uses, particularly for the treatment of dementia in the elderly. [258] The $1.415 billion penalty included an $800 million civil settlement, a $515 million criminal fine, and forfeit assets of $100 ...
Josiah Kirby Lilly Sr. (November 18, 1861 – February 8, 1948), nicknamed "J. K.," was an American businessman, pharmaceutical industrialist, and philanthropist who became president and chairman of the board of Eli Lilly and Company, the pharmaceutical firm his father, Colonel Eli Lilly, founded in 1876. Josiah, the colonel's sole heir, began ...
That, in turn, led to five Lilly sales reps contacting him in 2003 about Zyprexa, Risperdal’s Eli Lilly competitor. They told him that Lilly was selling the drug off-label to geriatrics. By late 2002, Sheller had filed a qui tam charging Lilly with false claims, through illegal sales of Prozac, Zyprexa and two other drugs to patients whose ...
Eli Lilly CEO Dave Ricks discusses the hot GLP-1 space and how his company is listening to patients' needs. ... Mounjaro raked in nearly $3 billion through the first nine months of 2023 alone, up ...
Indianapolis-based Eli Lilly (no. 142 on the Fortune 500) is the maker of Mounjaro, classified as Type 2 diabetes drug but which has led to weight loss among patients, and Zepbound, an obesity ...
Randall L. Tobias (born March 20, 1942) is an American governmental figure and former chief executive officer of Eli Lilly and Company.A Republican, he was appointed the first United States Director of Foreign Assistance, and served concurrently as the administrator of the U.S. Agency for International Development (USAID), with the rank of ambassador.
The drugs' removal from the shortage list is a positive for Eli Lilly in a couple of ways and could help the stock continue its strong run. Shares of Eli Lilly are up over 65% on the year.